ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Holding SPRY?
Track your performance easily

ARS Pharmaceuticals (SPRY) Technical Analysis

280 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is 0.25, suggesting ARS Pharmaceuticals is a Buy.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 12.45, while ARS Pharmaceuticals’s (SPRY) share price is $13.05, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 11.70, while ARS Pharmaceuticals’s (SPRY) share price is $13.05, making it a Buy.

ARS Pharmaceuticals (SPRY) Pivot Points

Sep 19, 2024, 10:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.10
12.50
12.72
13.12
13.34
13.74
13.96
Fibonacci
12.50
12.73
12.88
13.12
13.35
13.50
13.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

Sep 19, 2024, 10:51 PM
Period
Simple
Exponential
MA5
12.79Buy
12.78Buy
MA10
12.22Buy
12.59Buy
MA20
12.75Buy
12.45Buy
MA50
11.75Buy
11.70Buy
MA100
10.28Buy
10.61Buy
MA200
8.78Buy
8.80Buy
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 12.59, while ARS Pharmaceuticals’s (SPRY) share price is $13.05, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 10.61, while ARS Pharmaceuticals’s (SPRY) share price is $13.05, making it a Buy.
ARS Pharmaceuticals’s (SPRY) stock price is $13.05 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 11.75, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $13.05 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 10.28, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $13.05 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 8.78, creating a Buy signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

Sep 19, 2024, 10:51 PM
Name
Value
Implied Action
RSI (14)
56.70
Neutral
STOCH (9,6)
86.31
Sell
STOCHRSI (14)
66.18
Neutral
MACD (12,26)
0.25
Buy
ADX (14)
20.77
Neutral
Williams %R
-35.39
Buy
CCI (14)
17.60
Neutral
ATR (14)
0.78
-
Ultimate Oscillator
57.52
Neutral
ROC
-6.52
Sell
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 56.70, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 20.77, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is 17.60, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is -6.52, creating a Sell signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Strong Buy.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 56.70, which suggests SPRY is a Neutral.
      What is SPRY’s MACD?
      SPRY’s MACD is 0.25, which suggests SPRY is a Buy.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 12.79, which suggests SPRY is a Buy.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 12.75, which suggests SPRY is a Buy.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 11.75, which suggests SPRY is a Buy.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 8.78, which suggests SPRY is a Buy.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -35.39, which suggests SPRY is a Buy.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is 17.60, which suggests SPRY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis